Perrigo Co PLC (PRGO)

77.27
0.42 0.54
NYSE : Health Care
Prev Close 77.69
Open 77.50
Day Low/High 77.24 / 78.76
52 Wk Low/High 63.68 / 99.14
Volume 1.45M
Avg Volume 1.75M
Exchange NYSE
Shares Outstanding 142.61M
Market Cap 11.29B
EPS -28.00
P/E Ratio N/A
Div & Yield 0.64 (0.80%)

Latest News

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Stocks Tank as Trump, North Korea Exchange Barbs

Stocks Tank as Trump, North Korea Exchange Barbs

North Korea strikes Wall Street again.

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions

Perrigo Unveils Divestitures, Says It's Open to Making Bolt-On Acquisitions

The healthcare firm has agreed to sell its active pharmaceutical ingredients business and its Russia consumer healthcare international unit.

S&P 500 at Session Lows, Dow Under 22,000 on North Korea Threat

S&P 500 at Session Lows, Dow Under 22,000 on North Korea Threat

Stocks are lower.

Midday Report: Macy's Sinks Kohl's; Wall Street Down for Day Three

Midday Report: Macy's Sinks Kohl's; Wall Street Down for Day Three

Stocks fall for their third day in a row.

Dow Tumbles as North Korea Tensions Simmer

Dow Tumbles as North Korea Tensions Simmer

Stocks are lower.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Israel's Stock Market Is Having a Disastrous Week

Israel's Stock Market Is Having a Disastrous Week

Teva's not the only one struggling to stay afloat in Israel.

How You Can Beat the Still Astronomical Prices for Prescription Drugs

How You Can Beat the Still Astronomical Prices for Prescription Drugs

The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.

Activists Forced CEOs to Leave These Huge Companies This Year

Activists Forced CEOs to Leave These Huge Companies This Year

The top executives at these seven companies all left after pressure from activist investors in 2017.

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.